Drug Shortage Report for PRIVA-IRBESARTAN

Last updated on 2019-04-11 History
Report ID 81448
Drug Identification Number 02446510
Brand name PRIVA-IRBESARTAN
Common or Proper name IRBESARTAN 300 MG
Company Name PHARMAPAR INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) IRBESARTAN
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-09
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-04-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1565 BOUL LIONEL-BOULET
VARENNES, QUEBEC
CANADA J3X 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-04-11 French Compare
v1 2019-04-11 English Compare

Showing 1 to 2 of 2